TY - GEN A1 - Kislenko, Evgeniia T1 - Fluorescent molecularly imprinted polymers (MIPs) for sensing of phosphorylated protein epitopes N2 - Early detection of cancer is instrumental for successful therapeutic outcomes, but it is presently a considerable challenge. Biopsy of potentially cancerous tissues is the gold standard in medicine for the diagnosis and prognosis of this disease; however, it may not be possible in many cases due to tumour position or other complications. Liquid biopsy-based detection of specific cancer markers in biological fluids can be easily performed via immunoanalytical techniques. However, antibody-based methods suffer from high cost of tumour specific antibodies due to difficult and lengthy production. Furthermore, antibodies may have limited specificity to the target molecule, and limited lifetimes. The so-called “plastic antibodies” as MIPs can be a more affordable, reliable and stable alternative to antibodies, especially for cancer diagnostics. Our goal is to create MIP particles to selectively bind cancer biomarkers and rapidly display a fluorescence change upon interaction with molecules of interest. Epitopes containing the phosphorylated tyrosine (pY) motif such as tripeptide YpYG and tetrapeptide pYEEI were selected as target analytes. Cancers may disrupt tyrosine phosphorylation processes regulated by human tyrosine kinases such as ZAP-70 and subsequently lead to a pronounced increase in pY residues on proteins. To ensure fast diffusion of analyte and rapid response core/shell silica micro- and nanoparticles with a thin polymer shell was chosen as the format for MIP synthesis. Fluorescent probe monomers consisting of fluorophore and recognition units are directly integrated in the polymer shell to obtain fluorescence response upon analyte binding. We have synthesized the fluorescent MIP particles based on the previously published report [W. Wan et al., Chem. Eur. J., 2017, 23, 15974-1598] for the novel phosphorylated targets with a high imprinting factor and high degree of discrimination between target analyte and non-phosphorylated and smaller competitors. The synthesized particles may be used in microfluidic devices for the rapid diagnostics of cancer. T2 - GSSMIP2019 CY - Berlin, Germany DA - 28.08.2019 KW - Analytical Sciences KW - Sensorik PY - 2019 UR - https://opus4.kobv.de/opus4-bam/frontdoor/index/index/docId/50227 AN - OPUS4-50227 AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany